Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex
Juan-Juan Yin,1,2 Stepan P Shumyak,2 Christopher Burgess,2 Zhi-Wei Zhou,2 Zhi-Xu He,3 Xue-Ji Zhang,4 Shu-Ting Pan,2,5 Tian-Xin Yang,6 Wei Duan,7 Jia-Xuan Qiu,5 Shu-Feng Zhou21Xiaolan People’s Hospital, Southern Medical University, Zhongshan, Guangdong, People’s Republic of China;...
Enregistré dans:
Auteurs principaux: | Yin JJ, Shumyak SP, Burgess C, Zhou ZW, He ZX, Zhang XJ, Pan ST, Yang T, Duan W, Qiu JX, Zhou SF |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d35d04bebd564dab83d8f58d81183a62 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Estrogen-induced nongenomic calcium signaling inhibits lipopolysaccharide-stimulated tumor necrosis factor α production in macrophages.
par: Limin Liu, et autres
Publié: (2013) -
Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
par: Juan-Juan Yin, et autres
Publié: (2013) -
Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application
par: Song W, et autres
Publié: (2011) -
Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα
par: Liqun Chen, et autres
Publié: (2017) -
Construction and application of a liver cancer-targeting drug delivery system based on core–shell gold nanocages
par: Ji MF, et autres
Publié: (2018)